Publication | Closed Access

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma

Lymphoid NeoplasiaCell TherapyTransplantationOncologyMedicineStem Cell TransplantationImmunologyRadiation OncologyImmunotherapyCell Transplantation